Title | Surmounting structural barriers to tackle endemic infectious diseases. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Calderón F, Fairlamb AH, Strange M, Williams P, Nathan CF |
Journal | J Exp Med |
Volume | 218 |
Issue | 9 |
Date Published | 2021 Sep 06 |
ISSN | 1540-9538 |
Keywords | Academies and Institutes, Communicable Diseases, Drug Development, Drug Industry, Endemic Diseases, Humans, Public-Private Sector Partnerships |
Abstract | A unique experiment in bringing academic and industrial scientists together to tackle endemic infectious diseases has proved a success. The Tres Cantos Open Lab Foundation, guided and advised by independent experts, funds extended stays of academics at the campus of a pharmaceutical company, where they access the firm's resources in partnership with company scientists. Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has sustained the decade-long evolution of the model, whose distinctive features complement other public-private partnerships with similar goals. |
DOI | 10.1084/jem.20211418 |
Alternate Journal | J Exp Med |
PubMed ID | 34410327 |
PubMed Central ID | PMC8383816 |
Submitted by ljc4002 on August 21, 2025 - 2:36pm